닥플 플러스
2026 제67차 대한혈액학회 추계학술대회
대한혈액학회
연수평점 :6점
오프라인
주관
대한혈액학회
교육일자
2026-11-20
수강료
50,000원
교육형태
오프라인
등록일시
2026-09-14
교육시간
22시간
연수평점
6점
장소
서울특별시 더그랜드롯데 서울
교육종류
내과, 소아청소년과, 진단검사의학과
타임테이블
| 날짜 | 시간 | 강의명 | 강사 | 구분 |
|---|---|---|---|---|
| 2026-11-20 | 10:00~10:30 | Classification and Diagnostic Approach to MDS/MPN(Myelodysplastic Syndrome/Meloproliferative Neoplasm) Overlap Neoplasms | 이종미(가톨릭의대) | - |
| 2026-11-20 | 10:30~11:00 | Chronic Myelomonocytic Leukemia: Risk Stratification and Treatment | 장호철(전남의대) | - |
| 2026-11-20 | 11:00~11:30 | MDS/MPN with Neutrophilia (Atypical CML): Risk Stratification and Treatment | 이세원(이화의대) | - |
| 2026-11-20 | 11:30~12:00 | MDS/MPN with SF3B1 Mutation and Thrombocytosis: Treatment Strategies | 곽근예(고려의대) | - |
| 2026-11-20 | 10:00~10:40 | MRD Update in Adult ALL(Acute Lymphoblastic Leukemia) | 황상미(서울의대) | - |
| 2026-11-20 | 10:40~11:20 | Beyond Chemotherapy: MRD-Adapted Immunotherapy in Frontline Ph-Negative ALL | 유쾌한(서울의대) | - |
| 2026-11-20 | 11:20~12:00 | Optimizing Allogeneic HSCT(Hematopoietic Stem Cell Transplantation) in Adult ALL: Balancing Efficacy and Safety | 윤재호(가톨릭의대) | - |
| 2026-11-20 | 10:00~10:30 | Hepcidin and Anemia: From Pathophysiology to Clinical Decision Making | 최대호(성균관의대) | - |
| 2026-11-20 | 10:30~11:00 | NGS-Based Genetic Diagnosis of Inherited Anemia | 안아리(성균관의대) | - |
| 2026-11-20 | 11:00~11:30 | Understanding Pediatric AIHA: Clinical Cases and Recent Updates | 한승민(연세의대) | - |
| 2026-11-20 | 11:30~12:00 | Pediatric PNH Case Review | 박정아(인하의대) | - |
| 2026-11-20 | 12:00~13:00 | 점심 | - | - |
| 2026-11-20 | 13:00~13:30 | AML(Acute Myeloid Leukemia) & Transcriptomics | 김윤학(부산의대) | - |
| 2026-11-20 | 13:30~14:00 | The TIGIT/CD96/CD226 Axis Defines CD8+ T-Cell Exhaustion and Checkpoint Responsiveness in AML | 이지민(KAIST) | - |
| 2026-11-20 | 14:00~14:30 | The Study of DNA Damage Response in CML(Chronic Myeloid Leukemia) | 김홍태(UNIST) | - |
| 2026-11-20 | 14:30~15:00 | Genomic Research in Multiple Myeloma | 고영일(서울의대) | - |
| 2026-11-20 | 13:00~13:30 | Preventive Management Before and During TKI Therapy | 공지현(연세의대) | - |
| 2026-11-20 | 13:30~14:00 | Drug–Drug Interactions with TKIs: An In-Depth Review | 권소연(서울의대) | - |
| 2026-11-20 | 14:00~14:30 | Managing CML in Reproductive-Age Patients: Pregnancy, Lactation, and Male Fertility | 박현경(울산의대) | - |
| 2026-11-20 | 14:30~15:00 | Revising the KSH CML Guideline: Expert Survey Results | 최은지(울산의대) | - |
| 2026-11-20 | 13:00~13:30 | Ultra-Long-Acting Factor Replacement Therapies: Efanesoctocog Alfa and Beyond | 박영실(경희의대) | - |
| 2026-11-20 | 13:30~14:00 | Non-Factor Therapies: Marstacimab and Emerging Therapies | 김보람(전남의대) | - |
| 2026-11-20 | 14:00~14:30 | Case 1. Hemophilia C (Factor XI Deficiency) | 이해원(연세의대) | - |
| 2026-11-20 | 14:30~15:00 | Case 2. Factor VII Deficiency | 최영배(아주의대) | - |
| 2026-11-20 | 13:00~13:30 | MedDRA for Big Data: Standardization, Interoperability, and Analysis | 도윤희(MedDRA MSSO) | - |
| 2026-11-20 | 13:30~14:00 | Vibe Coding | 신승환(가톨릭의대) | - |
| 2026-11-20 | 14:00~14:30 | NGS Data Anlysis | 이세민( UNIST) | - |
| 2026-11-20 | 14:30~15:00 | AI Based CDS in CML | 김동욱(을지의대) | - |
| 2026-11-20 | 15:00~15:30 | 휴식 | - | - |
| 2026-11-20 | 15:30~16:00 | Treatment of Transplant-Eligible Newly Diagnosed Multiple Myeloma | 정성훈(전남의대) | - |
| 2026-11-20 | 16:00~16:30 | Treatment of Transplant-Ineligible Newly Diagnosed and Earlier-Line Relapsed/Refractory Multiple Myeloma | 임호영(전북의대) | - |
| 2026-11-20 | 16:30~17:00 | The Evolution of CAR T-Cell Therapy and Antibodies in the Management of Multiple Myeloma | 김진석(연세의대) | - |
| 2026-11-20 | 17:00~17:30 | Discussion | - | - |
| 2026-11-20 | 15:30~16:00 | Clonal Hematopoiesis: Biology and Mechanism of Action | 신새암(연세의대) | - |
| 2026-11-20 | 16:00~16:30 | Clonal Hematopoiesis and Blood Cancers | 조현수(서울의대) | - |
| 2026-11-20 | 16:30~17:00 | Monoclonal Gammopathy of Undetermined Significance | 김미영(울산의대) | - |
| 2026-11-20 | 17:00~17:30 | Monoclonal B-Cell Lymphocytosis and T-Cell Clones of Undetermined Significance | 김선영(서울의대) | - |
| 2026-11-20 | 15:30~16:00 | Rethinking LCH(Langerhans Cell Histiocytosis): Highlights and Controversies | 서진경(서울의대) | - |
| 2026-11-20 | 16:00~16:30 | Rethinking HLH(Hemophagocytic Lymphohistiocytosis): Highlights and Controversies | 심예지(경북의대) | - |
| 2026-11-20 | 16:30~17:00 | Rethinking Relapsed LCH(Langerhans Cell Histiocytosis): Targets, Timing, Toxicity | 최정윤(서울의대) | - |
| 2026-11-20 | 17:00~17:30 | Rethinking Refractory HLH(Hemophagocytic Lymphohistiocytosis): Control, Bridge, Transplant | 강성한(울산의대) | - |
| 2026-11-20 | 15:30~16:00 | The CAT Odyssey: From the Guidelines to Daily Practice | 홍준식(서울의대) | - |
| 2026-11-20 | 16:00~16:30 | Recurrent Thrombosis or Bleeding During Anticoagulation for CAT | 김경하(순천향의대) | - |
| 2026-11-20 | 16:30~17:00 | New Drugs, Old Problem: CAT in the Era of Targeted Therapy and Immunotherapy | 박영훈(이화의대) | - |
| 2026-11-20 | 17:00~17:30 | Discussion | - | - |
비고
전문의 : 50,000원 / 전공의, 간호사, 관련업체 : 20,000원
문의처
담당자
윤빛나
연락처
02-516-6581
이메일
hematology@kams.or.kr